BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32976486)

  • 1. Sociodemographic data and APOE-ε4 augmentation for MRI-based detection of amnestic mild cognitive impairment using deep learning systems.
    Pelka O; Friedrich CM; Nensa F; Mönninghoff C; Bloch L; Jöckel KH; Schramm S; Sanchez Hoffmann S; Winkler A; Weimar C; Jokisch M;
    PLoS One; 2020; 15(9):e0236868. PubMed ID: 32976486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.
    Spasov S; Passamonti L; Duggento A; Liò P; Toschi N;
    Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroimaging basis in the conversion of aMCI patients with APOE-ε4 to AD: study protocol of a prospective diagnostic trial.
    Chen GQ; Sheng C; Li YX; Yu Y; Wang XN; Sun Y; Li HY; Li XY; Xie YY; Han Y
    BMC Neurol; 2016 May; 16():64. PubMed ID: 27176479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multi-model deep convolutional neural network for automatic hippocampus segmentation and classification in Alzheimer's disease.
    Liu M; Li F; Yan H; Wang K; Ma Y; ; Shen L; Xu M
    Neuroimage; 2020 Mar; 208():116459. PubMed ID: 31837471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automated MRI-Based Deep Learning Model for Detection of Alzheimer's Disease Process.
    Feng W; Halm-Lutterodt NV; Tang H; Mecum A; Mesregah MK; Ma Y; Li H; Zhang F; Wu Z; Yao E; Guo X
    Int J Neural Syst; 2020 Jun; 30(6):2050032. PubMed ID: 32498641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of hippocampal volume and serum brain-derived neurotrophic factor as potential diagnostic markers of conversion from amnestic mild cognitive impairment to Alzheimer disease: A STROBE-compliant article.
    Fang Y; Du N; Xing L; Duo Y; Zheng L
    Medicine (Baltimore); 2019 Jul; 98(30):e16604. PubMed ID: 31348306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive Composites Domain Scores Related to Neuroimaging Biomarkers within Probable-Amnestic Mild Cognitive Impairment-Storage Subtype.
    Espinosa A; Alegret M; Pesini P; Valero S; Lafuente A; Buendía M; San José I; Ibarria M; Tejero MA; Giménez J; Ruiz S; Hernández I; Pujadas F; Martínez-Lage P; Munuera J; Arbizu J; Tárraga L; Hendrix SB; Ruiz A; Becker JT; Landau SM; Sotolongo-Grau O; Sarasa M; Boada M; ;
    J Alzheimers Dis; 2017; 57(2):447-459. PubMed ID: 28269787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic classification of mild cognitive impairment and Alzheimer's disease: MRI independent component analysis.
    Willette AA; Calhoun VD; Egan JM; Kapogiannis D;
    Psychiatry Res; 2014 Nov; 224(2):81-8. PubMed ID: 25194437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Random forest feature selection, fusion and ensemble strategy: Combining multiple morphological MRI measures to discriminate among healhy elderly, MCI, cMCI and alzheimer's disease patients: From the alzheimer's disease neuroimaging initiative (ADNI) database.
    Dimitriadis SI; Liparas D; Tsolaki MN;
    J Neurosci Methods; 2018 May; 302():14-23. PubMed ID: 29269320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting Imminent Progression to Clinically Significant Memory Decline Using Volumetric MRI and FDG PET.
    Stonnington CM; Chen Y; Savage CR; Lee W; Bauer RJ; Sharieff S; Thiyyagura P; Alexander GE; Caselli RJ; Locke DEC; Reiman EM; Chen K
    J Alzheimers Dis; 2018; 63(2):603-615. PubMed ID: 29630550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-Diadem: a constrained dual-input deep learning model to identify novel biomarkers in Alzheimer's disease.
    Jemimah S; AlShehhi A;
    BMC Med Genomics; 2023 Oct; 16(Suppl 2):244. PubMed ID: 37833700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interaction of APOE genotype by age in amnestic mild cognitive impairment: a voxel-based morphometric study.
    Chen J; Shu H; Wang Z; Liu D; Shi Y; Zhang X; Zhang Z
    J Alzheimers Dis; 2015; 43(2):657-68. PubMed ID: 25114090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer's disease diagnosis from diffusion tensor images using convolutional neural networks.
    Marzban EN; Eldeib AM; Yassine IA; Kadah YM;
    PLoS One; 2020; 15(3):e0230409. PubMed ID: 32208428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Automated classification of Alzheimer's disease and mild cognitive impairment using a single MRI and deep neural networks.
    Basaia S; Agosta F; Wagner L; Canu E; Magnani G; Santangelo R; Filippi M;
    Neuroimage Clin; 2019; 21():101645. PubMed ID: 30584016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
    Löwe LC; Gaser C; Franke K;
    PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex modulates the ApoE ε4 effect on brain tau deposition measured by
    Liu M; Paranjpe MD; Zhou X; Duy PQ; Goyal MS; Benzinger TLS; Lu J; Wang R; Zhou Y
    Theranostics; 2019; 9(17):4959-4970. PubMed ID: 31410194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration and relative value of biomarkers for prediction of MCI to AD progression: spatial patterns of brain atrophy, cognitive scores, APOE genotype and CSF biomarkers.
    Da X; Toledo JB; Zee J; Wolk DA; Xie SX; Ou Y; Shacklett A; Parmpi P; Shaw L; Trojanowski JQ; Davatzikos C;
    Neuroimage Clin; 2014; 4():164-73. PubMed ID: 24371799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of apolipoprotein E genotype on magnetic resonance spectrum in amnestic mild cognitive impairment and Alzheimer's disease patients].
    Zhu XQ; Zhou X; Zhao W; Zhang YM; Liu FJ; Cao J; Sun ZW
    Zhonghua Yi Xue Za Zhi; 2019 Apr; 99(15):1156-1161. PubMed ID: 31006219
    [No Abstract]   [Full Text] [Related]  

  • 19. Quantitative electroencephalography (qEEG), apolipoprotein A-I (APOA-I), and apolipoprotein epsilon 4 (APOE ɛ4) alleles for the diagnosis of mild cognitive impairment and Alzheimer's disease.
    Niu X; Wang Y; Zhang X; Wang Y; Shao W; Chen L; Yang Z; Peng D
    Neurol Sci; 2024 Feb; 45(2):547-556. PubMed ID: 37673807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hierarchical feature representation and multimodal fusion with deep learning for AD/MCI diagnosis.
    Suk HI; Lee SW; Shen D;
    Neuroimage; 2014 Nov; 101():569-82. PubMed ID: 25042445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.